You have read all your free articles, to continue reading subscribe to read the rest of this content.
Spago Nanomedical has announced new results which show that the company's candidate drug Tumorad significantly reduces tumor growth and prolongs survival in a preclinical model for colorectal cancer. Together with previously communicated clinical and preclinical results, the new results provide aAlready a subscriber Login You have read all your free…
Vitamin B3 (nicotinamide) may prevent nerve cell damage leading to blindness in glaucoma, according to the world’s first clinical study in the field published in Clinical and Experimental Ophthalmology. The study was led by researchers at the Centre for Eye Research Australia in collaboration wAlready a subscriber Login You have…
According to new report, produced Ministry of Employment and the Economy, Finland’s private pharmaceutical research sector could more than double in size by the year 2020. For a long time, Finland has been a popular location for pharmaceutical research. However, in recent years the number of clAlready a subscriber Login…
IRLAB Therapeutics have announced that its partner Ipsen has initiated clinical studies with drug candidate mesdopetam in accordance with its development plan. These are standard clinical pharmacokinetic studies that will run in parallel to the Phase IIb study with mesdopetam that is currently beAlready a subscriber Login You have read…
